FDA Warns Philips Over Fatal Defibrillator Defects
The medical device unit of Royal Philips Electronics NV received a warning letter from the U.S. Food and Drug Administration in late March advising the company that its failure to correct...To view the full article, register now.
Already a subscriber? Click here to view full article